Abstract
The obtained results have confirmed the efficacy of Nuclex in terms of normalisation of parameters of coronary reserve, and in terms of elimination of the main signs and symptoms of influenza and acute upper respiratory tract infection (URTI), in particular, Normalisation of body temperature, disappearance of headache, catarrhal phenomena, and general fatigue. The decrease in intensity of these signs and symptoms in the study group appeared one to three days earlier than in the control group, and this difference remained significant until the end of treatment. On the 14th day of Nuclex intake influenza A virus H1N1 could not be found by means of PCR in 58.33% of the study group patients, meanwhile in the control group patients the virus was still detectable. The results have clearly demonstrated the significant difference in the treatment efficacy between the control and study groups thus favouring the latter. Nuclex has been proven effective to completely remove the influenza virus from the body.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Behavioural and Healthcare Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
